Dr Fei Deng
Dr Deng is currently a researcher at the Graduate School of Biomedical Engineering, Â鶹Éçmadou. Dr Deng received his Ph.D. degree (specialising in point-of-care biosensing and Biomedical Engineering, 2021) from the University of New South Wales (Â鶹Éçmadou), Sydney, Australia. Dr Deng’s research interests include point-of-care biosensing device, CRISPR biosensing device and in vivo biosensing device. To date, Dr Deng has published over 30 journal articles, including Nature Communications, AFM, Small etc. In addition, he has secured over $10M research grants, including AEA, CRCP, NHMRC Idea Grant, ARC Discovery Project etc. His biosensor research has been well recognized by industry, leading to a startup company (Casbio Pty Ltd, co-founder) and a research consultant of Avicena Systems Limited.
Ìý
Editorial Activities:
- Associate Editor for Diagnostic and Therapeutic Devices, Frontiers in Medical Technology.Ìý
- The host of Bio-focus seminar (2022), CNBP Node at Graduate School of Biomedical Engineering.Ìý
Ìý
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
Ìý
- Australia's Economic Accelerator, CIA
- Cooperative Research Centres Projects, 2024-2026, co-CIÌý
- Â鶹Éçmadou-Tsinghua Collaborative Research Seed Program, 2023, co-CI
- NHMRC Idea Grant, 2024-2026, co-CIÌý
- ARC Discovery Project, 2024-2026, co-CIÌý
- Â鶹Éçmadou_NMHA Seed Funidng, 2023, co-CI
- Torch Innovation, 2023, CIAÌý
- Health Security Systems Australia, 2023, co-CI.Ìý
- NSSN Grand Challenge Fund, 2023, co-CI.Ìý
- 3Rs Grant from Â鶹Éçmadou, 2022, co-CI.
- Industry competitive research award, 2022-2024, co-CI.
- Two Innovation connections grants, 2021 (RG211246, RG210091),ÌýCI on both.
- One EDI and ECAN seed funding from Â鶹Éçmadou, 2021, CIA.
- Australian Centre for NanoMedicine (ACN) Travel Award (2023)
- Diversity in Engineering Academic Visitors Funding Award (2023)
- Â鶹Éçmadou Engineering ECA Awards – Innovation and Engagement Award (2022)
- Diversity in Engineering Academic Visitors Funding Award (2023)
- ARC Centre for Nanoscale BioPhotonics (CNBP) Travel Award (2022)
- Australian Centre for NanoMedicine (ACN) Travel Award (2022)
- PhD Scholarship in Sandwich assay based deployable biosensors (2017-2021)
- Excellent Graduate Thesis (Master, 2016)
- Foreigners Scholarship (Master, 2013-2016)
- Secondary Prize of Tianjin chemistry competition (Bachelor, 2011)
Patent
- CRISPR/Cas-associated detection assays, methods and kits. (2023) PCT Patent. International application No. PCT/AU2022/050829. Ìý
- Ultrasensitive CRISPR biosensors assisted by nucleic acid mediators. (2023) PCT Patent. International application No. PCT/AU2023/051144. Ìý
- Biosensor. (2023) Australian provisional patent No. P0046904AU
Ìý
My Research Supervision
PhD Supervision Experience
- Co-supervisingÌýPhD research project: Development ofÌý rapid and sensitive methods for the detection of waterborne pathogensÌý, 2024 (J. Arona)
- Co-supervisingÌýPhD research project: Programmable nucleases and applications in biosensing, 2023 (X. Zhai)
- Joint-supervisingÌýPhD research project: Novel biosensors for exosome detection, 2023 (P. Mohammadnejad)
- Co-supervisingÌýPhD research project: Capture and detection of waterborne parasites using existing and emergent technologies, 2021 (T. Hall)
Ìý
Ìý ÌýThesis students
- Primary-supervisedÌýPG Thesis project: CRISPR/Cas powered aptasensor for the point-of-care diagnosis of IBD (K. Lyu), 2024
- Primary-supervisedÌýPG Thesis project: Precision diagnosis of single gene diseases using CRISPR technology (Y. Lin), 2024
- Primary-supervisedÌýUG Thesis project: Precision diagnosis of inflammatory bowel disease using CRISPR technology (S. Xue), 2023-2024
- Primary-supervised UG Thesis project: CRISPR/Cas12a Mediated Biosensing Assay for Point-of-Care Testing of Calprotectin (S. Chia), 2023
- Primary-supervised PG Thesis project: Point-of-care testing of procalcitonin using lateral flow assay (J. Deodhar), 2023
My Teaching